Skip to main contentSkip to breadcrumbsSkip to sub navSkip to doormat

Johannes Zuber

The genetic complexity, heterogeneity and plasticity of human cancers pose daunting challenges for the development of effective targeted therapies. New functional genetic tools such as CRISPR/Cas9, RNAi and targeted protein degradation have fundamentally changed the way we can approach this problem. Our lab develops and employs these tools to systematically identify and mechanistically study key regulators and dependencies in genetically engineered cancer models and tumor-associated immune cells.

Group Members

Florian ANDERSCH
Bioinformatician
Jonas Fridolin BAYERL
Master Student
Michaela FELLNER
Research Assistant
Lisa-Maria FRASZ
Master Student
Robert Wolfgang KALIS
PhD Student
Sophie LOIDOLT
Master Student
Martina MINNICH
Research Associate
Gabriel PABST
PhD Student
Emanuele ROVERA
PhD Student
Bettina SAJTOS
PhD Student
Markus SCHÄFER
Postdoc
Johannes SCHMÖLLERL
Postdoc
Mariia STUPCHUK
Research Technician
Vivien VOGT
PhD Student
Martina WEIßENBÖCK
Senior Research Assistant
Helena Nicoletta WOLF
Master Student
Jakub ZMAJKOVIC
Postdoc
Johannes ZUBER
Senior Group Leader